{
  "question": "\nThe User asks a question, and you solve it. \nYou first generate the reasoning and thinking process and then provide the User with the final answer.\n\nDuring the thinking process, **you can generate python code** for efficient searching, optimization, and computing with the format of starting the python block with ```python. \n**A code query must involve only a single script that uses 'print' function for the output.**. \nOnce the code script is complete, stop the generation. Then, the code interpreter platform will execute the code and return the execution output and error.\n\nIf you lack the related knowledge, you can use the Google Search Tool to search the web and get the information.\nYou can call a search query with the format of <search>your search query</search>, e.g., <search>Who is the current president of US?</search>. The searched results will be returned between <information> and </information>.\nOnce the search query is complete, stop the generation. Then, the search platform will return the searched results.\n\nIf you need to search the web, do not generate code in the same response. Vice versa. You can also solve the question without code and searching, just by your textual reasoning.\n\nOnce you feel you are ready for the final answer, directly return the answer with the format <<<answer content>>> at the end of your response.\nOtherwise, you can continue your reasoning process and possibly generate more code or search queries to solve the problem.\n\n    question: You identified a new ligand-receptor pair initially expressed in the neural crest cells and want to understand the developmental fate of their interaction. The receptor is a monomeric transmembrane barrel with eight alpha helices, four extracellular helices, and three beta sheets that create a binding site for the ligand. The ligand is a coiled-coil of two alpha helices. You create a bicistronic lox-Cre vector with the ligand ORF at the 5' position, fused to mCherry; the receptor ORF is at the 3' and fused to the eGFP at the C-terminus. The ligand is under the CBA promoter, and upstream of the receptor is the IRES regulatory element. Between the ligand ORF and mCherry, there is a stop in a loxP-stop-loxP cassette, and between the receptor and the eGFP, there is a stop in the lox2272-stop-lox2272 cassette. You had also raised antibodies against the overexpressed proteins and now use them to test the construct expression on the Western blot after plasmid transfection to primary astrocyte culture. Total proteins give a signal proportional to the actin loading. You finally breed a mouse model homozygous for your construct in the wt background. You cross it to SOX10-Cre hemizygous mice; after the offspring is born you visualize them under the fluorescent confocal microscope. You do not observe a green signal. Which of the answers below explains the most likely reason for it?\n\nA) the enhancer for the ligand and receptor expression is missing\nB) the receptor-eGFP construct is stuck in the Golgi\nC) the receptor and the eGFP are not in the frame\nD) ligand and the receptor are in a paracrine relationship\n\nOnce you feel you are ready for the final answer, directly return the answer with the format <<<answer content>>> at the end of your response, e.g. <<<C>>>, <<<A>>>\n",
  "response_list": [
    "Here is a breakdown of the reasoning process to determine the correct answer:\n\n1.  **Analyze the genetic construct:**\n    *   The construct is a bicistronic vector, meaning it's designed to express two separate proteins from a single messenger RNA (mRNA) transcript.\n    *   The entire construct is driven by a single CBA promoter, which is a strong, ubiquitous promoter. This means it should be active in many cell types, including the target cells.\n    *   The first open reading frame (ORF) is for the ligand, and the second is for the receptor. An IRES (Internal Ribosome Entry Site) element is placed between them. This allows ribosomes to start translation independently on the second ORF (the receptor).\n    *   The mCherry fluorescent tag is intended to be fused to the ligand, but a `loxP-stop-loxP` cassette separates them. This is a \"conditional knockout\" or \"Cre-On\" system. The stop codon prevents mCherry expression until Cre recombinase removes the cassette.\n    *   Similarly, the eGFP fluorescent tag is intended to be fused to the C-terminus of the receptor, but a `lox2272-stop-lox2272` cassette separates them. This also requires Cre recombinase to remove the stop cassette for eGFP to be expressed. Lox2272 sites are a variant of loxP sites and are also recognized by Cre recombinase.\n\n2.  **Analyze the mouse cross:**\n    *   The construct mouse is crossed with a SOX10-Cre mouse.\n    *   SOX10 is a transcription factor that is a key marker for neural crest cells. This means that Cre recombinase will be expressed specifically in the neural crest cells and their developmental derivatives.\n    *   In the offspring, in SOX10-expressing cells, Cre recombinase will be present and will act on both the `loxP` sites and the `lox2272` sites.\n    *   Cre-mediated recombination will excise the DNA between the two identical lox sites, removing the \"stop\" sequence in both cassettes.\n\n3.  **Analyze the consequence of Cre-mediated recombination:**\n    *   When Cre recombinase excises the `loxP-stop-loxP` or `lox2272-stop-lox2272` cassette, it leaves a single copy of the lox site behind.\n    *   The final mRNA in the Cre-expressing cells should be `Ligand - [single loxP site] - mCherry - IRES - Receptor - [single lox2272 site] - eGFP`.\n    *   The key technical detail is the length of the remaining lox site. A lox site (both loxP and its variants like lox2272) is 34 base pairs long.\n    *   For two proteins to be fused together correctly (like the Receptor and eGFP), the sequence linking them must have a length that is a multiple of three. This ensures that the reading frame is maintained.\n    *   The length of the residual lox2272 site is 34 base pairs. `34 / 3 = 11` with a remainder of `1`.\n    *   Because 34 is not a multiple of 3, the insertion of this 34 bp lox2272 site between the receptor ORF and the eGFP ORF will cause a frameshift.\n    *   This frameshift means that the codons for the eGFP protein will be read incorrectly, leading to the translation of a garbage polypeptide and almost certainly a premature stop codon. No functional eGFP protein will be produced.\n\n4.  **Evaluate the given options:**\n    *   **A) the enhancer for the ligand and receptor expression is missing:** This is incorrect. The construct uses the strong and ubiquitous CBA promoter, which does not require a specific tissue enhancer to function.\n    *   **B) the receptor-eGFP construct is stuck in the Golgi:** While possible that a misfolded protein could be retained in the ER/Golgi, a complete absence of signal is more strongly explained by a failure of protein synthesis. Also, there is no specific information to suggest a protein folding defect.\n    *   **C) the receptor and the eGFP are not in the frame:** This is the most likely explanation. As detailed above, the residual 34 bp lox2272 site left after Cre recombination causes a frameshift, preventing the correct translation of the eGFP protein. This is a common and critical error in designing such fusion protein constructs.\n    *   **D) ligand and the receptor are in a paracrine relationship:** This describes the biological mode of action of the proteins (cell-to-cell signaling). It has no bearing on whether the reporter eGFP protein can be successfully synthesized from the engineered construct within a single cell.\n\n**Conclusion:** The lack of a green signal is due to a frameshift mutation introduced by the residual lox2272 site, preventing the synthesis of a functional eGFP protein.\n\n<<<C>>>",
    "The user wants me to identify the most likely reason for the absence of a green fluorescent signal in a transgenic mouse model.\n\n### Reasoning and Thinking Process\n\n1.  **Deconstruct the Experimental Design:**\n    *   **Vector:** A single bicistronic plasmid is used. This means one mRNA molecule is transcribed, which is intended to produce two separate proteins.\n    *   **Promoter:** The CBA promoter drives the expression. CBA (Chicken Beta-Actin) is a strong and ubiquitous promoter, meaning it should drive expression in most cell types, including the target neural crest cells.\n    *   **First Gene (Cistron 1):** Ligand, followed by a `loxP-stop-loxP` cassette, followed by mCherry. This is a \"Cre-On\" system. Without Cre recombinase, translation hits the stop codon, and mCherry is not produced. With Cre, the stop cassette is removed, allowing the translation of a Ligand-mCherry fusion protein.\n    *   **Inter-cistronic Element:** An IRES (Internal Ribosome Entry Site) is placed between the first and second gene regions. This element allows the ribosome to bind directly to the middle of the mRNA and start translating the second protein, independent of the first.\n    *   **Second Gene (Cistron 2):** Receptor, followed by a `lox2272-stop-lox2272` cassette, followed by eGFP at the C-terminus. This is another \"Cre-On\" system. Without Cre, the stop codon prevents eGFP expression. With Cre, the stop cassette is removed, allowing the translation of a Receptor-eGFP fusion protein.\n    *   **Mouse Cross:** The mouse carrying this construct is crossed with a SOX10-Cre mouse. SOX10 is a marker for neural crest cells. This means that Cre recombinase will be expressed specifically in neural crest cells and their descendants.\n\n2.  **Analyze the Molecular Event in Target Cells:**\n    *   In the offspring's SOX10-positive cells, Cre recombinase is present.\n    *   Cre recombinase recognizes and acts on both `loxP` and `lox2272` sites.\n    *   It will excise the DNA between the `loxP` sites and the DNA between the `lox2272` sites.\n    *   After excision, a single `loxP` site remains between the ligand and mCherry, and a single `lox2272` site remains between the receptor and eGFP.\n\n3.  **Focus on the Problem: No Green Signal (eGFP)**\n    *   The green signal comes from the eGFP protein, which is supposed to be fused to the C-terminus of the receptor.\n    *   For this fusion to be successful, the coding sequence of the receptor and the coding sequence of eGFP must be in the same translational reading frame.\n    *   Let's consider the consequence of the `lox2272` recombination event. The event removes the stop cassette but leaves behind one copy of the `lox2272` site.\n    *   A `lox` site (both `loxP` and its variants like `lox2272`) is 34 base pairs (bp) long.\n    *   For a fusion protein to be translated correctly, the length of any intervening \"scar\" DNA must be a multiple of 3 (since codons are 3 bases long). If it's not, a frameshift mutation occurs.\n    *   The length of the `lox2272` scar is 34 bp. `34 / 3 = 11` with a remainder of `1`.\n    *   Because 34 is not a multiple of 3, the `lox2272` scar will shift the reading frame. The ribosome, after translating the receptor, will read the eGFP sequence in the wrong frame.\n    *   This frameshift will result in the production of a nonsense polypeptide instead of eGFP, and a premature stop codon will almost certainly be encountered. Therefore, no functional eGFP protein will be synthesized.\n\n4.  **Evaluate the Options:**\n    *   **A) the enhancer for the ligand and receptor expression is missing:** This is incorrect. The strong, ubiquitous CBA promoter is present and should be active.\n    *   **B) the receptor-eGFP construct is stuck in the Golgi:** While misfolded proteins can be retained in the ER/Golgi, a complete lack of signal is more robustly explained by a complete failure to synthesize the protein in the first place. The frameshift is a more fundamental and certain problem.\n    *   **C) the receptor and the eGFP are not in the frame:** This is the most accurate explanation. The 34 bp `lox2272` scar left after Cre-mediated recombination causes a frameshift mutation, preventing the correct translation of eGFP.\n    *   **D) ligand and the receptor are in a paracrine relationship:** This describes a biological mode of interaction between cells. It has no bearing on whether the eGFP reporter protein is successfully synthesized inside the cell that expresses the receptor gene.\n\n**Conclusion:** The lack of a green signal is a direct consequence of a frameshift mutation introduced by the residual `lox2272` site, a common pitfall when designing Cre-lox-based fusion proteins.\n\n<<<C>>>",
    "This problem describes a sophisticated genetic engineering experiment. Let's break down the components to identify the likely point of failure.\n\n### Reasoning and Thinking Process\n\n1.  **Analyze the Genetic Construct:** The core of the experiment is a bicistronic vector designed to be conditionally activated by Cre recombinase.\n    *   **Promoter:** The CBA promoter is strong and should drive expression in most cells, including the target neural crest cells after the mouse is generated. So, a lack of promoter/enhancer activity is unlikely to be the primary issue.\n    *   **Bicistronic Design:** The vector is designed to produce two proteins (Ligand and Receptor) from a single mRNA transcript, using an IRES element. The IRES allows ribosomes to start translation on the second protein (the receptor) independently. This is a standard and functional design.\n    *   **Conditional Activation (Cre-On):** Both fluorescent reporters (mCherry and eGFP) are downstream of \"lox-stop-lox\" cassettes (`loxP-stop-loxP` and `lox2272-stop-lox2272`). This means they are only expressed *after* Cre recombinase has been introduced and has removed the stop cassettes.\n    *   **The Cross:** The construct mouse is crossed with a SOX10-Cre mouse. SOX10 is a well-established marker for neural crest cells. This means that in the offspring, Cre recombinase will be specifically expressed in neural crest cells, which is the intended cell population. The experimental design to turn on the reporters in the correct cells is sound.\n\n2.  **Focus on the Molecular Event of Cre Recombination:**\n    *   The problem states that no green signal (eGFP) is observed. The green signal should come from a Receptor-eGFP fusion protein.\n    *   For the eGFP to be expressed, Cre recombinase must successfully remove the `lox2272-stop-lox2272` cassette. Cre is known to recognize and act on `lox2272` sites.\n    *   When Cre mediates recombination between two `lox` sites, it excises the intervening DNA (the \"stop\" sequence) but leaves behind a single copy of the `lox` site as a \"scar\" in the DNA.\n    *   So, after recombination, the coding sequence will be: `[Receptor ORF] - [lox2272 site] - [eGFP ORF]`.\n\n3.  **The Critical Detail: The Reading Frame.**\n    *   For two proteins to be successfully fused together (like the Receptor and eGFP), the sequence that connects them must maintain the translational reading frame. A protein's amino acid sequence is determined by reading the mRNA in groups of three bases (codons). If an insertion or deletion occurs that is not a multiple of three bases, the reading frame is shifted, and all subsequent codons are read incorrectly.\n    *   The key question is: what is the length of the `lox2272` scar? A standard `loxP` site, and its variants like `lox2272`, is **34 base pairs** long.\n    *   Since 34 is not a multiple of 3 (34 ÷ 3 = 11 with a remainder of 1), the insertion of this 34 bp scar between the coding sequence of the receptor and the coding sequence of eGFP will cause a **frameshift mutation**.\n    *   Due to this frameshift, the ribosome will translate the receptor correctly, but once it passes the scar, it will begin to read the eGFP sequence in the wrong frame. This will result in a nonsense string of amino acids and almost certainly encounter a premature stop codon.\n    *   Therefore, a functional, fluorescent eGFP protein will not be synthesized.\n\n4.  **Evaluating the Options:**\n    *   **A) the enhancer for the ligand and receptor expression is missing:** This is incorrect. The strong, ubiquitous CBA promoter is provided.\n    *   **B) the receptor-eGFP construct is stuck in the Golgi:** This would imply the protein is synthesized but improperly folded or trafficked. A frameshift is a more fundamental problem; the correct protein is never synthesized in the first place, making this a much more likely explanation for a complete lack of signal.\n    *   **C) the receptor and the eGFP are not in the frame:** This is the correct conclusion. The 34 bp `lox2272` scar introduces a frameshift, preventing the proper translation of eGFP. This is a classic error in designing Cre-inducible fusion proteins.\n    *   **D) ligand and the receptor are in a paracrine relationship:** This describes how the two proteins might function biologically between cells. It has no bearing on whether the eGFP reporter protein is successfully produced *within* the cell that expresses the construct.\n\n<<<C>>>",
    "Here is a step-by-step breakdown of the reasoning to determine the correct answer.\n\n1.  **Analyze the experimental design.** The goal is to track cells that have expressed a specific ligand-receptor pair originating in the neural crest. A bicistronic vector is used, where a single mRNA is transcribed, but an IRES element allows two separate proteins to be translated from it. The expression of the reporter genes (mCherry and eGFP) is made conditional using Cre-Lox technology.\n\n2.  **Analyze the genetic construct.**\n    *   **Promoter:** The CBA promoter is strong and generally active in a wide range of cells. This means transcription of the construct's mRNA should not be an issue.\n    *   **Conditional Expression:** The reporters are downstream of `lox-stop-lox` cassettes. mCherry is downstream of a `loxP-stop-loxP` cassette, and eGFP is downstream of a `lox2272-stop-lox2272` cassette. These stop cassettes prevent the translation of the fluorescent proteins.\n    *   **The Cre Driver:** A `SOX10-Cre` mouse line is used. SOX10 is a transcription factor expressed in neural crest cells. This ensures that Cre recombinase, the enzyme that acts on `lox` sites, is present specifically in the cells of interest.\n\n3.  **Trace the molecular events in a target cell (a SOX10-expressing neural crest cell).**\n    *   In these cells, the SOX10 promoter drives the expression of Cre recombinase.\n    *   Cre recombinase recognizes the `loxP` and `lox2272` sites in the construct's DNA.\n    *   Cre will excise the \"stop\" sequence located between the two identical `lox` sites.\n    *   Crucially, after excision, a single copy of the `lox` site remains in the DNA as a \"scar\".\n    *   Therefore, the mRNA sequence for the receptor and its fluorescent tag will correspond to: `[Receptor coding sequence] - [lox2272 scar] - [eGFP coding sequence]`.\n\n4.  **Focus on the problem: The absence of the green (eGFP) signal.**\n    *   For the eGFP protein to be correctly synthesized as a fusion to the C-terminus of the receptor, the translational reading frame must be preserved. The genetic code is read in codons of three bases. Any insertion or deletion that is not a multiple of three bases will cause a frameshift.\n    *   A standard `lox` site (both `loxP` and its variant `lox2272`) is **34 base pairs** long.\n    *   When the `lox2272` scar is left between the receptor's coding sequence and the eGFP's coding sequence, it inserts 34 bp of DNA.\n    *   34 is not divisible by 3 (34 / 3 = 11 with a remainder of 1).\n    *   This insertion of 34 base pairs will shift the reading frame. The ribosome will translate the receptor protein correctly, but after traversing the scar, it will read the codons for eGFP incorrectly. This leads to the synthesis of a non-functional polypeptide and almost certainly results in a premature stop codon. No functional eGFP can be produced.\n\n5.  **Evaluate the given options:**\n    *   **A) the enhancer for the ligand and receptor expression is missing:** This is incorrect. The construct has the strong CBA promoter, which drives expression. The purpose of the SOX10-Cre is to *activate the reporters* in specific cells, not to drive the initial transcription.\n    *   **B) the receptor-eGFP construct is stuck in the Golgi:** While a misfolded protein can be retained in the cell's secretory pathway, a frameshift mutation is a more fundamental problem. It prevents the correct protein from being synthesized in the first place, providing a definitive reason for a complete lack of signal.\n    *   **C) the receptor and the eGFP are not in the frame:** This is the correct explanation. The 34 bp `lox2272` scar left after Cre-mediated recombination causes a frameshift mutation, which prevents the successful translation of the eGFP protein. This is a common and critical technical error in designing such fusion constructs.\n    *   **D) ligand and the receptor are in a paracrine relationship:** This describes a potential biological mechanism of how the cells communicate. It has no bearing on the intracellular process of protein synthesis and whether the eGFP reporter can be successfully translated from its mRNA.\n\n<<<C>>>",
    "This problem requires a detailed understanding of molecular cloning, Cre-Lox systems, and protein translation. Let's break down the experiment to find the most likely reason for the failure.\n\n### Reasoning and Thinking Process\n\n1.  **Analyze the Vector and its Components:**\n    *   **Promoter:** The construct is driven by the CBA (Chicken Beta-Actin) promoter. This is a strong, ubiquitous promoter, meaning it should drive high levels of transcription in most cell types, including the target neural crest cells. Therefore, a lack of expression due to a missing enhancer is unlikely.\n    *   **Bicistronic Design:** The construct is designed to produce two proteins from one mRNA transcript using an IRES (Internal Ribosome Entry Site). This is a standard technique. The ribosome translates the first ORF (ligand), and then the IRES allows the ribosome to re-initiate translation on the second ORF (receptor). This part of the design is sound.\n    *   **Conditional Reporters:** The expression of both fluorescent tags (mCherry and eGFP) is conditional. They are located behind \"lox-stop-lox\" cassettes. This means that they will only be expressed if a Cre recombinase enzyme is present to cut out the \"stop\" sequence.\n    *   **The Specific Cassettes:**\n        *   Ligand-mCherry fusion is blocked by a `loxP-stop-loxP` cassette.\n        *   Receptor-eGFP fusion is blocked by a `lox2272-stop-lox2272` cassette. `lox2272` is a variant of `loxP` that is still recognized and cut by Cre recombinase.\n\n2.  **Analyze the Mouse Cross and the Intended Outcome:**\n    *   The construct mouse is crossed with a `SOX10-Cre` mouse. SOX10 is a transcription factor that is a definitive marker for neural crest cells. This cross correctly targets the expression of Cre recombinase to the intended cell population.\n    *   In the offspring's neural crest cells, Cre recombinase will be present. It will recognize both the `loxP` and `lox2272` sites.\n    *   Cre will excise the stop cassettes.\n    *   The intended outcome is the expression of a Ligand-mCherry fusion protein and a Receptor-eGFP fusion protein in SOX10-positive cells.\n\n3.  **Identify the Problem:**\n    *   The observation is a **lack of green signal (eGFP)**. We need to find the specific flaw in the design of the Receptor-eGFP fusion.\n    *   When Cre recombinase excises the DNA between two `lox` sites, it leaves a single copy of the `lox` site behind in the DNA. This remaining `lox` site is often called a \"scar.\"\n    *   So, after recombination, the gene sequence will be: `[Receptor ORF] - [one lox2272 site] - [eGFP ORF]`.\n    *   For the Receptor and eGFP proteins to be fused correctly, their coding sequences must be in the same **translational reading frame**. The genetic code is read in triplets (codons). If the number of base pairs in the linking scar is not a multiple of 3, a frameshift mutation will occur.\n\n4.  **The Critical Calculation:**\n    *   We need to know the length of the `lox2272` site. A `lox` site (both `loxP` and its variants) is **34 base pairs** long.\n    *   Is 34 divisible by 3? No. `34 / 3 = 11` with a remainder of `1`.\n    *   Because the 34 bp scar is not a multiple of 3, it will shift the reading frame.\n    *   The ribosome will correctly translate the receptor protein. However, when it reads through the `lox2272` scar, its reading frame will be shifted by one base. As a result, the subsequent mRNA sequence for eGFP will be read as a completely different set of codons, producing a nonsense polypeptide. This incorrect sequence will almost certainly include a premature stop codon, terminating translation.\n    *   Therefore, no functional eGFP protein can be synthesized. This directly explains the lack of a green signal.\n\n5.  **Evaluate the Options:**\n    *   A) the enhancer for the ligand and receptor expression is missing: Incorrect. The CBA promoter is strong and active.\n    *   B) the receptor-eGFP construct is stuck in the Golgi: This would imply the protein was synthesized but misfolded. The frameshift is a more fundamental error preventing synthesis in the first place, making it the most likely cause for a complete absence of signal.\n    *   C) the receptor and the eGFP are not in the frame: **Correct.** The 34 bp scar from the `lox2272` site causes a frameshift mutation, which aborts the translation of a functional eGFP protein.\n    *   D) ligand and the receptor are in a paracrine relationship: This describes the biological function of the proteins (cell-to-cell signaling) and is irrelevant to the technical process of protein synthesis within the cell.\n\n<<<C>>>"
  ],
  "user_prompt_list": [
    "\nThe User asks a question, and you solve it. \nYou first generate the reasoning and thinking process and then provide the User with the final answer.\n\nDuring the thinking process, **you can generate python code** for efficient searching, optimization, and computing with the format of starting the python block with ```python. \n**A code query must involve only a single script that uses 'print' function for the output.**. \nOnce the code script is complete, stop the generation. Then, the code interpreter platform will execute the code and return the execution output and error.\n\nIf you lack the related knowledge, you can use the Google Search Tool to search the web and get the information.\nYou can call a search query with the format of <search>your search query</search>, e.g., <search>Who is the current president of US?</search>. The searched results will be returned between <information> and </information>.\nOnce the search query is complete, stop the generation. Then, the search platform will return the searched results.\n\nIf you need to search the web, do not generate code in the same response. Vice versa. You can also solve the question without code and searching, just by your textual reasoning.\n\nOnce you feel you are ready for the final answer, directly return the answer with the format <<<answer content>>> at the end of your response.\nOtherwise, you can continue your reasoning process and possibly generate more code or search queries to solve the problem.\n\n    question: You identified a new ligand-receptor pair initially expressed in the neural crest cells and want to understand the developmental fate of their interaction. The receptor is a monomeric transmembrane barrel with eight alpha helices, four extracellular helices, and three beta sheets that create a binding site for the ligand. The ligand is a coiled-coil of two alpha helices. You create a bicistronic lox-Cre vector with the ligand ORF at the 5' position, fused to mCherry; the receptor ORF is at the 3' and fused to the eGFP at the C-terminus. The ligand is under the CBA promoter, and upstream of the receptor is the IRES regulatory element. Between the ligand ORF and mCherry, there is a stop in a loxP-stop-loxP cassette, and between the receptor and the eGFP, there is a stop in the lox2272-stop-lox2272 cassette. You had also raised antibodies against the overexpressed proteins and now use them to test the construct expression on the Western blot after plasmid transfection to primary astrocyte culture. Total proteins give a signal proportional to the actin loading. You finally breed a mouse model homozygous for your construct in the wt background. You cross it to SOX10-Cre hemizygous mice; after the offspring is born you visualize them under the fluorescent confocal microscope. You do not observe a green signal. Which of the answers below explains the most likely reason for it?\n\nA) the enhancer for the ligand and receptor expression is missing\nB) the receptor-eGFP construct is stuck in the Golgi\nC) the receptor and the eGFP are not in the frame\nD) ligand and the receptor are in a paracrine relationship\n\nOnce you feel you are ready for the final answer, directly return the answer with the format <<<answer content>>> at the end of your response, e.g. <<<C>>>, <<<A>>>\n",
    "<information>\nExtra search: </information>",
    "<information>\nExtra search: </information>",
    "<information>\nExtra search: </information>",
    "<information>\nExtra search: </information>",
    "<information>\nExtra search: </information>"
  ],
  "system_message": ""
}